Intaprost T Eye Drop

Intaprost T Eye Drop is a combination of two medicines used to treat pressure in the eyes (ocular hypertension) and glaucoma. It works by decreasing the pressure of fluid in the eye (aqueous humor), which helps in lowering the increased eye pressure.

Intaprost T Eye Drop is to be used only in the affected eye in the dose and duration as advised by the doctor. Wash your hands before using this medicine. Check the label thoroughly for directions before use. Do not skip any doses and finish the full course of treatment even if you feel better.

The most common side effects include burning, irritation, itching, and redness at the application site. If these side effects persist for a longer duration, inform your doctor. In case by accident, this medicine goes into your ears, nose, or mouth, immediately rinse it with plenty of water.

Inform your doctor if you have a known allergy to any of the ingredients of this medicine. It is advised not to drive or operate heavy machinery after the use of this medicine as it may cause temporary blurring of vision and may affect your ability to drive.

• Treatment of Glaucoma
• Treatment of Ocular hypertension

Treatment of Glaucoma
Glaucoma is an eye disease that damages the optic nerve which is essential for proper vision. This damage is often caused by an abnormally high pressure in the eye. Intaprost T Eye Drop is used to reduce swelling and pressure inside the eye. This helps prevent complications of glaucoma such as blindness and improves the vision. This medicine may be used alone or with other eye drops. Glaucoma cannot be prevented. Frequent monitoring, regular checkups can help detect the disease in its early stages.

Treatment of Ocular hypertension
Ocular hypertension is a condition where the pressure inside the eye is higher than normal eye pressure due to fluid build-up. Intaprost T Eye Drop increases the flow of fluid from inside the eye into the bloodstream thereby lowering the increased eye pressure. This prevents further damage or complications such as change in vision or even loss of vision. You should only use Intaprost T Eye Drop in the affected eye and take it regularly as prescribed by your doctor.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Ganfort

• Application site reactions (burning, irritation, itching and redness)
• Blurred vision

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.

Intaprost T Eye Drop is a combination of two medicines: Bimatoprost and Timolol. Bimatoprost is a prostaglandin analogue while Timolol is a beta blocker. They work by decreasing the production of aqueous humour (fluid in the eye), thereby lowering the increased eye pressure.

• You have been prescribed Intaprost T Eye Drop to lower high pressure in the eye and reduce the risk of vision loss.
• Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the drop.
• If you wear soft contact lenses, remove them before putting in these eye drops and wait at least 15 minutes before putting your lenses back in.
• Do not touch the tip of the dropper to any surface, or to your eye, to avoid contaminating the eye drops.
• It may cause short term blurring of vision when first used. Use caution before driving or using machines.
• It may temporarily cause your eyelashes to grow longer, darker, and thicker. This is not harmful.
• It may cause brown pigmentation of the eye when used long-term. This may be permanent but is not harmful.
• Make sure to use within 4 weeks of opening the bottle.

Timolol maleate + bimatoprost. Marlow, Bucks: Allergan Ltd.; 2006 [revised 06 Apr. 2017]. [Accessed 15 Apr. 2019] (online) Available from:

European Medicine Agency. Bimatoprost + Timolol; 2006. [Accessed 15 Apr. 2019] (online) Available from: